REGEN BIOPHARMA, INC. Notes Payable, Current
REGEN BIOPHARMA, INC. (RGBP) had Notes Payable, Current of $210.36 thousand as of 2025-03-31, per its 10-Q filed 2025-05-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2025-05-28
- 2025-03-31: Notes Payable, Current $210.36K.
- 2024-12-31: Notes Payable, Current $107.51K.
- 2024-09-30: Notes Payable, Current $293.82K.
- 2024-06-30: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current |
|---|---|
| 2025-03-31 | $210.36K 10-Q · filed 2025-05-28 |
| 2024-12-31 | $107.51K 10-Q · filed 2025-05-16 |
| 2024-09-30 | $293.82K 10-Q · filed 2025-05-28 |
| 2024-06-30 | $0.00 10-K · filed 2025-05-13 |
| 2023-12-31 | $49.21K 10-Q · filed 2024-01-19 |
| 2023-09-30 | $95.71K 10-K · filed 2025-05-13 |
| 2022-09-30 | $710.00 10-K · filed 2023-11-20 |
| 2021-09-30 | $9.06K 10-K · filed 2021-12-22 |